T-cell-prolymphocytic Leukemia
Also known as: T-Prolymphocytic Leukemia / T-cell Prolymphocytic Leukemia (T-PLL) / T Cell Prolymphocytic Leukemia / T-cell prolymphocytic leukaemia / T-Cell Prolymphocytic Leukemia / Leukemia, Prolymphocytic, T-Cell / Prolymphocytic leukemia of T-cell type not having achieved remission / Prolymphocytic leukemia of T-cell type / T-cell prolymphocytic leukemia (disorder) / Prolymphocytic leukemia, T-cell type (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00087 | Alemtuzumab | A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis. |